|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010592,
umls-concept:C0023911,
umls-concept:C0150369,
umls-concept:C0184511,
umls-concept:C0205210,
umls-concept:C0376387,
umls-concept:C0439568,
umls-concept:C0441889,
umls-concept:C1274040,
umls-concept:C1527178,
umls-concept:C1705938
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-3-29
|
|
pubmed:abstractText |
A prospective, open-label, study was conducted at 29 centers in 9 countries, involving 307 de novo liver transplant patients to compare the clinical usefulness of monitoring 2-hr post-dose cyclosporine (CsA) levels (C2) with conventional trough cyclosporine blood levels (pre-dose) (C0).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
pubmed-author:BurriHH,
pubmed-author:CavallariAA,
pubmed-author:DuvouxCC,
pubmed-author:JohnstonAA,
pubmed-author:LakeJJ,
pubmed-author:LevyGG,
pubmed-author:MayerA DAD,
pubmed-author:MiesSS,
pubmed-author:PollardS GSG,
pubmed-author:VasePP,
pubmed-author:VillamilFF
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
953-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11923699-Administration, Oral,
pubmed-meshheading:11923699-Alkaline Phosphatase,
pubmed-meshheading:11923699-Bilirubin,
pubmed-meshheading:11923699-Continental Population Groups,
pubmed-meshheading:11923699-Cyclosporine,
pubmed-meshheading:11923699-Drug Monitoring,
pubmed-meshheading:11923699-Female,
pubmed-meshheading:11923699-Hepatitis B,
pubmed-meshheading:11923699-Hepatitis C,
pubmed-meshheading:11923699-Humans,
pubmed-meshheading:11923699-Immunosuppressive Agents,
pubmed-meshheading:11923699-Liver Transplantation,
pubmed-meshheading:11923699-Male,
pubmed-meshheading:11923699-Middle Aged,
pubmed-meshheading:11923699-Proportional Hazards Models,
pubmed-meshheading:11923699-Regression Analysis,
pubmed-meshheading:11923699-Safety,
pubmed-meshheading:11923699-Time Factors
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).
|
|
pubmed:affiliation |
Department of Medicine, Toronto General Hospital, M5G 2C4 Toronto, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
